DOUBLE-BLIND CONTROLLED CROSSOVER TRIAL OF 4-PERCENT INTRANASAL SODIUM CROMOGLYCATE SOLUTION IN PATIENTS WITH SEASONAL ALLERGIC RHINITIS

  • 1 January 1982
    • journal article
    • research article
    • Vol. 49  (3) , 131-134
Abstract
In a double-blind, controlled, crossover study involving 47 subjects documented with seasonal allergic rhinitis, repeated intranasal administration of 4% sodium cromoglycate solution was associated with significant reduction in symptoms and decrease in consumption of antihistaminic drugs. Side effects were mild and transitory. Intranasal sodium cromoglycate administration is an efficacious preventive and therapeutic approach in the management of patients with seasonal allergic rhinitis.

This publication has 1 reference indexed in Scilit: